ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Comera Life Sciences Holdings Inc

Comera Life Sciences Holdings Inc (CMRA)

0.045
0.00
(0.00%)
終了 12月21日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.045
買値
0.0451
売値
0.065
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
0.045
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
30,737,796
配当利回り
-
PER
-0.07
1 株当たり利益 (EPS)
-0.6
歳入
633k
純利益
-18.38M

Comera Life Sciences Holdings Inc について

Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting a formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is... Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting a formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-

CMRA 最新ニュース

Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a proprietary drug-delivery...

Comera Life Sciences Announces Process Exploring Strategic Alternatives

WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a new generation of biologic...

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve...

Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

– Final stage of technical evaluation near completion in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Expanded and strengthened Comera’s global patent...

Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

Comera Life Sciences Announces the Completion of $4.1 Million Private Placement

WOBURN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities

Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN...

Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights

– Advanced to final stage of technical evaluation in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Received notice that Nasdaq granted Comera’s request...

Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform

WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

Comera Life Sciences Announces $4.1 Million Private Placement

WOBURN, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CMRA - Frequently Asked Questions (FAQ)

What is the current Comera Life Sciences share price?
The current share price of Comera Life Sciences is US$ 0.045
How many Comera Life Sciences shares are in issue?
Comera Life Sciences has 30,737,796 shares in issue
What is the market cap of Comera Life Sciences?
The market capitalisation of Comera Life Sciences is USD 1.38M
What is the 1 year trading range for Comera Life Sciences share price?
Comera Life Sciences has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Comera Life Sciences?
The price to earnings ratio of Comera Life Sciences is -0.07
What is the cash to sales ratio of Comera Life Sciences?
The cash to sales ratio of Comera Life Sciences is 1.94
What is the reporting currency for Comera Life Sciences?
Comera Life Sciences reports financial results in USD
What is the latest annual turnover for Comera Life Sciences?
The latest annual turnover of Comera Life Sciences is USD 633k
What is the latest annual profit for Comera Life Sciences?
The latest annual profit of Comera Life Sciences is USD -18.38M
What is the registered address of Comera Life Sciences?
The registered address for Comera Life Sciences is 1521 CONCORD PIKE SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19803
What is the Comera Life Sciences website address?
The website address for Comera Life Sciences is comeralifesciences.com
Which industry sector does Comera Life Sciences operate in?
Comera Life Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

CMRA Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock